Cirrhosis Clinical Trials

Find clinical trials for Cirrhosis. Search for Cirrhosis clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 94

EMPower MechanismsEMPower Mechanisms

Recruiting

Sponsor:

University of Alberta

Location:

Edmonton

Code:

NCT06861465

Conditions

Primary Biliary Cholangitis (PBC)

Eligibility Criteria

Sex: Female

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Online Mind-Body Wellness Program

Online Mind-Body Wellness Program + Nutritional Counselling

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Homewood AL, Chandler AZ, Flagstaff AZ, Peoria AZshow 83 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

Hepatic Encephalopathy and Albumin Lasting Cognitive ImprovementHepatic Encephalopathy and Albumin Lasting Cognitive Improvement

Recruiting

PHASE2

Sponsor:

Hunter Holmes Mcguire Veteran Affairs Medical Center

Location:

Richmond VA

Code:

NCT06052176

Conditions

Cirrhosis

Hepatic Encephalopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Albumin Infusion

Online Prehabilitation for Patients Awaiting Liver TransplantationOnline Prehabilitation for Patients Awaiting Liver Transplantation

Recruiting

Sponsor:

University of Alberta

Location:

Edmonton

Code:

NCT05899231

Conditions

Cirrhosis, Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Prehabilitation Programming

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Flagstaff AZ, Scottsdale AZ, Tucson AZ, Canoga Park CAshow 95 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis PatientsNEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients

Recruiting

PHASE2

PHASE3

Sponsor:

UCLA

Location:

San Francisco CA

Code:

NCT06000748

Conditions

Acute Kidney Injury

Cirrhosis

Portal Hypertension

Hepatorenal Syndrome

Acute Tubule Necrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MAP-Target Algorithm

Canadian Network for Autoimmune Liver DiseaseCanadian Network for Autoimmune Liver Disease

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Calgary, Edmonton, Vancouver, Winnipegshow 9 more

Code:

NCT03569826

Conditions

Primary Bilary Cirrhosis (PBC)

Autoimmune Hepatitis

Overlap Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Observational; no intervention

IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)

Recruiting

PHASE3

Sponsor:

Gilead Sciences

Location:

Chandler AZ, Pasadena CA, Sacramento CA, San Francisco CAshow 28 more

Code:

NCT06060665

Conditions

Primary Biliary Cholangitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Seladelpar 10 mg

Placebo

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Recruiting

PHASE3

Sponsor:

Madrigal Pharmaceuticals, Inc.

Location:

Birmingham AL, Chandler AZ, Peoria AZ, Tucson AZshow 45 more

Code:

NCT05500222

Conditions

NASH

Cirrhosis, Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Resmetirom

Placebo

Family Studies in Primary Biliary Cirrhosis (PBC)Family Studies in Primary Biliary Cirrhosis (PBC)

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Toronto

Code:

NCT00242125

Conditions

Biliary Cirrhosis, Primary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted